폐 스텐트 시장 : 시장 기회, 성장요인, 업계 동향 분석 및 예측(2026-2035년)

The Global Lung Stent Market was valued at USD 175.9 million in 2025 and is estimated to grow at a CAGR of 9.5% to reach USD 432.5 million by 2035.

Growth in the lung stents industry is supported by the increasing burden of respiratory disorders, rising prevalence of lung cancer, and growing occurrence of chronic airway complications worldwide. Lung stents, commonly referred to as airway stents, are specialized implantable medical devices designed to restore and maintain airway openness in patients experiencing airway narrowing or obstruction caused by severe respiratory conditions, trauma, infections, or structural abnormalities. These devices are manufactured using silicone, metal alloys, and hybrid materials to address diverse clinical requirements and improve long-term patient outcomes. The market is also benefiting from advancements in minimally invasive pulmonary procedures and increasing adoption of interventional pulmonology techniques across healthcare facilities. Growing awareness regarding early respiratory intervention and improved access to advanced healthcare services are further contributing to market expansion. In addition, rising investments from both public and private organizations in the development of advanced non-vascular stent technologies are accelerating product innovation. Increasing cases of chronic obstructive pulmonary disease and airway narrowing following tuberculosis treatment are also creating sustained demand for lung stent procedures globally.

The tracheal stents segment accounted for a share of 69.1% in 2025, supported by the growing need for effective airway stabilization and immediate restoration of airflow in patients with severe tracheal complications. Tracheal stents continue to represent the leading product category in the lung stents market because of their critical role in maintaining central airway patency in complex respiratory interventions. These stents are extensively used in procedures involving airway compression, structural airway collapse, and severe respiratory obstruction requiring long-term support. Their strong positional stability, reliable structural integrity, and ability to deliver immediate clinical improvement have increased their adoption across hospitals and specialty respiratory care centers.

The self-expandable segment is anticipated to register a CAGR of 9.6% and reach USD 341.3 million by 2035. Self-expandable lung stents remain highly preferred due to their flexibility, adaptability to irregular airway structures, and ability to provide continuous radial support after placement. These stents are widely used in complex airway procedures because they can conform effectively to compressed or anatomically challenging airway passages while supporting minimally invasive treatment approaches. Their compatibility with bronchoscopic deployment techniques has significantly increased clinical acceptance across healthcare institutions. Continuous improvements in alloy composition, structural performance, and stent engineering have further enhanced procedural precision and in-body stability.

North America Lung Stent Market accounted for 43.1% share in 2025. The regional market continues to benefit from the high prevalence of respiratory diseases and the growing number of lung cancer diagnoses across the United States and Canada. Strong healthcare infrastructure, advanced respiratory treatment capabilities, and widespread availability of specialized pulmonary care services are supporting increased utilization of lung stent technologies throughout the region. North America also demonstrates high adoption of interventional pulmonology procedures, supported by strong clinician expertise and growing awareness regarding advanced airway management techniques. In addition, favorable reimbursement structures and increasing investments in respiratory healthcare technologies are strengthening market penetration. Ongoing innovation in bronchoscopic procedures, improved patient screening programs, and rising healthcare expenditure are further contributing to regional market expansion. The increasing focus on improving respiratory care outcomes and reducing complications associated with airway obstruction is expected to support continued demand for lung stents across North America.

Major companies operating in the Global Lung Stent Market include Boston Scientific, TaeWoong MEDICAL, Teleflex, Renata Medical, HEALTH MICROPORT MEDICAL, EFER ENDOSCOPY, MICRO-TECH ENDOSCOPY, ENDO-FLEX, MERIT MEDICAL, Peytant, COOK GROUP, mi-TECH, NOVATECH, Standard Sci Tech, STENING, and HOOD LABORATORIES. Companies participating in the lung stent market are implementing several strategic initiatives to strengthen their market presence and expand their competitive positioning. Leading manufacturers are investing heavily in research and development activities to improve stent flexibility, biocompatibility, structural durability, and deployment accuracy for complex airway procedures. Businesses are also focusing on product innovation involving hybrid materials, minimally invasive delivery systems, and patient-specific airway solutions to enhance clinical outcomes. Strategic collaborations with hospitals, respiratory care centers, and interventional pulmonology specialists are helping companies improve product adoption and expand their distribution networks. In addition, manufacturers are increasing investments in emerging healthcare markets to strengthen geographic reach and capitalize on growing respiratory care demand.

Table of Contents

Chapter 1 Research Methodology

• 1.1 Research approach
• 1.2 Quality commitments
  • 1.2.1 GMI AI policy & data integrity commitment
    • 1.2.1.1 Source consistency protocol
• 1.3 Research trail & confidence scoring
  • 1.3.1 Research trail components
  • 1.3.2 Scoring components
• 1.4 Data collection
  • 1.4.1 Partial list of primary sources
• 1.5 Data mining sources
  • 1.5.1 Paid sources
    • 1.5.1.1 Sources, by region
• 1.6 Base estimates and calculations
  • 1.6.1 Base year calculation
• 1.7 Forecast model
  • 1.7.1 Quantified market impact analysis
    • 1.7.1.1 Mathematical impact of growth parameters on forecast
• 1.8 Research transparency addendum
  • 1.8.1 Source attribution framework
  • 1.8.2 Quality assurance metrics
  • 1.8.3 Our commitment to trust

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product trends
  • 2.2.3 Device type trends
  • 2.2.4 Material trends
  • 2.2.5 Patient trends
  • 2.2.6 End use trends
• 2.3 CXO perspectives: Strategic imperatives

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising prevalence of lung cancer
    • 3.2.1.2 Growing incidence of COPD and post-tuberculosis stenosis
    • 3.2.1.3 Increasing investments by the public and private organizations for the development of non-vascular stents
    • 3.2.1.4 Growing preference for minimally invasive surgeries for respiratory disorders
    • 3.2.1.5 Technological advancements in stent design
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 Availability of alternative substitute treatment
    • 3.2.2.2 Stringent regulations
  • 3.2.3 Opportunities
    • 3.2.3.1 Integration of digital health and remote monitoring
    • 3.2.3.2 Expansion in emerging healthcare markets
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Pricing trend analysis
• 3.6 Technology and innovation landscape (Driven by Primary Research)
  • 3.6.1 Current technological trends
  • 3.6.2 Emerging technologies
• 3.7 Future market trends (Driven by Primary Research)
• 3.8 Reimbursement scenario
• 3.9 Impact of AI & Generative AI on the Market (Driven by Primary Research)
• 3.10 Porter's analysis
• 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2025

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis (Driven by Primary Research)
  • 4.3.1 Global
  • 4.3.2 North America
  • 4.3.3 Europe
  • 4.3.4 Asia Pacific
  • 4.3.5 LAMEA
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers & acquisitions
  • 4.6.2 Partnerships & collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2022 - 2035 ($ Mn)

• 5.1 Key trends
• 5.2 Tracheal stents
• 5.3 Bronchial stents
• 5.4 Laryngeal stents

Chapter 6 Market Estimates and Forecast, By Device Type, 2022 - 2035 ($ Mn)

• 6.1 Key trends
• 6.2 Self-expandable
• 6.3 Balloon-expandable

Chapter 7 Market Estimates and Forecast, By Material, 2022 - 2035 ($ Mn)

• 7.1 Key trends
• 7.2 Silicone
• 7.3 Metal
  • 7.3.1 Stainless steel
  • 7.3.2 Nitinol
• 7.4 Hybrid

Chapter 8 Market Estimates and Forecast, By Patient, 2022 - 2035 ($ Mn)

• 8.1 Key trends
• 8.2 Adult
• 8.3 Pediatric

Chapter 9 Market Estimates and Forecast, By End Use, 2022 - 2035 ($ Mn)

• 9.1 Key trends
• 9.2 Hospitals
• 9.3 Ambulatory surgical centers
• 9.4 Other end users

Chapter 10 Market Estimates and Forecast, By Region, 2022 - 2035 ($ Mn)

• 10.1 Key trends
• 10.2 North America
  • 10.2.1 U.S.
  • 10.2.2 Canada
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 France
  • 10.3.4 Spain
  • 10.3.5 Italy
  • 10.3.6 Netherlands
• 10.4 Asia Pacific
  • 10.4.1 China
  • 10.4.2 Japan
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 South Korea
• 10.5 Latin America
  • 10.5.1 Brazil
  • 10.5.2 Mexico
  • 10.5.3 Argentina
• 10.6 MEA
  • 10.6.1 South Africa
  • 10.6.2 Saudi Arabia
  • 10.6.3 UAE

Chapter 11 Company Profiles

• 11.1 Boston Scientific
• 11.2 COOK GROUP
• 11.3 EFER ENDOSCOPY
• 11.4 ENDO-FLEX
• 11.5 HEALTH MICROPORT MEDICAL
• 11.6 HOOD LABORATORIES
• 11.7 MERIT MEDICAL
• 11.8 MICRO-TECH ENDOSCOPY
• 11.9 mi-TECH
• 11.10 NOVATECH
• 11.11 Peytant
• 11.12 Renata Medical
• 11.13 Standard Sci Tech
• 11.14 STENING
• 11.15 TaeWoong MEDICAL
• 11.16 Teleflex